Evidence map›Paper›PMID 42175449›Full record

ArticleMedicine2026

Tech-based evaluation of healthcare quality during the COVID-19 pandemic.

Kang Wang, Ruixiang Xu, Qian Huang

Abstract read
In one paragraph

Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kang WangSchool of Management, Capital Normal University, Beijing, China.
Ruixiang XuSchool of Management, Beijing University of Chinese Medicine, Beijing, China.
Qian HuangDepartment of Respiratory Medicine, Beijing Tian Tan Hospital, Capital Medical University, Beijing, China.ORCID 0009-0005-3018-3666

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The coronavirus disease 2019 pandemic profoundly disrupted global health systems, exacerbating preexisting inequalities in access to and quality of care. Disparities in service accessibility, continuity, coordination, and comprehensiveness highlight the need for a multidimensional, data-driven approach to healthcare evaluation. We conducted a retrospective analysis using 52,490 responses from the 2021 Global Burden of Disease COVID-19 Health Service Disruption Survey. We developed a 4-dimensional evaluation framework aligned with World Health Organization principles for people-centered care. Following variable selection, standardized preprocessing, and manual labeling, we trained and assessed 6 machine learning (ML) algorithms. We further optimized the 2 best-performing models - support vector machine (SVM) and random forest (RF) - using interpolation-based data augmentation, cross-validated hyperparameter tuning, and particle swarm optimization. SVM showed the highest baseline performance (accuracy 0.93), whereas RF achieved competitive macro-F1 scores. Interpolation-based data augmentation improved the generalizability of the SVM model, increasing its accuracy to 0.96. The RF model benefited most from particle swarm optimization-based hyperparameter optimization. Model predictions revealed persistent inequalities in healthcare service quality: respondents with lower income, lower educational attainment, and rural residence were disproportionately classified as receiving lower-quality services, whereas urban residence and higher income were associated with higher-quality care. Our scalable ML framework successfully assessed healthcare service quality during the pandemic, with optimized SVM and RF models demonstrating robust performance on high-dimensional, imbalanced survey data. Post-pandemic recovery strategies must prioritize socioeconomically disadvantaged populations. Furthermore, integrating ML tools can enhance real-time quality monitoring within health systems.

Indexed as

COVID-19Quality of Health CareHumansMachine LearningPandemicsParticle Swarm OptimizationRandom ForestRetrospective StudiesSARS-CoV-2Support Vector MachineCOVID-19Global Burden of Diseasehealthcare service qualitymachine learningrandom forestsupport vector machine

Identifiers

PMID42175449
PMCPMC13200972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.